PODD Stock Price, Chart, Stats & News

Insulet Corporation
Save
10.14B
Market cap
34.27x
Current P/E
23.87x
Forward P/E
PODD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 71.63% |
Operating margin | 17.50% |
Pretax margin | 12.54% |
Net margin | 9.12% |
Effective tax rate | 27.19% |
ROA | 7.75% |
ROE | 17.36% |
D/E | 0.69x |
Interest coverage ratio | 7.40x |
PODD valuation
P/E | 34.27x |
P/S | 5.41x |
P/B | 9.67x |
P/CF | 25.74x |
P/FCF | 38.81x |
P/OCF | 25.74x |
PEG | 207.52x |
EV multiple | 29.44x |
About
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.
Similar securities
Based on sector and market capitalization
Report issue











